416 related articles for article (PubMed ID: 35226309)
21. Immune checkpoint inhibitors in NSCLC.
Johnson DB; Rioth MJ; Horn L
Curr Treat Options Oncol; 2014 Dec; 15(4):658-69. PubMed ID: 25096781
[TBL] [Abstract][Full Text] [Related]
22. [Clinical Development of Immunotherapy for Small Cell Lung Cancer].
Yu T; Zhong D
Zhongguo Fei Ai Za Zhi; 2018 Dec; 21(12):918-923. PubMed ID: 30591100
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy versus standard chemotherapy for treatment of extensive-stage small-cell lung cancer: a systematic review.
Liu X; Xing H; Zhang H; Liu H; Chen J
Immunotherapy; 2021 Aug; 13(12):989-1000. PubMed ID: 34114477
[TBL] [Abstract][Full Text] [Related]
24. Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors.
Reddy HG; Qin A; Kalemkerian GP
Expert Opin Emerg Drugs; 2020 Sep; 25(3):353-366. PubMed ID: 32683991
[TBL] [Abstract][Full Text] [Related]
25. Personalized Therapy of Small Cell Lung Cancer.
Schneider BJ; Kalemkerian GP
Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
[TBL] [Abstract][Full Text] [Related]
26. Immune Checkpoint Inhibitors and Chemoradiation for Limited-Stage Small Cell Lung Cancer.
Schlick B; Shields MD; Marin-Acevedo JA; Patel I; Pellini B
Curr Treat Options Oncol; 2022 Aug; 23(8):1104-1120. PubMed ID: 35716328
[TBL] [Abstract][Full Text] [Related]
27. [Immunotherapy Advances in Small Cell Lung Cancer].
Xu Y; Zhan P; Song Y
Zhongguo Fei Ai Za Zhi; 2020 Nov; 23(11):989-998. PubMed ID: 32752583
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy for Advanced Lung Cancer.
Asmar R; Rizvi NA
Cancer J; 2015; 21(5):383-91. PubMed ID: 26389763
[TBL] [Abstract][Full Text] [Related]
29. Immunotherapy in Lung Cancer.
Castellanos EH; Horn L
Cancer Treat Res; 2016; 170():203-23. PubMed ID: 27535396
[TBL] [Abstract][Full Text] [Related]
30. Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Partially Realized Potential.
Armstrong SA; Liu SV
Adv Ther; 2019 Aug; 36(8):1826-1832. PubMed ID: 31209697
[TBL] [Abstract][Full Text] [Related]
31. Current and future therapeutic approaches for the treatment of small cell lung cancer.
Rossi A; Tay R; Chiramel J; Prelaj A; Califano R
Expert Rev Anticancer Ther; 2018 May; 18(5):473-486. PubMed ID: 29544351
[TBL] [Abstract][Full Text] [Related]
32. The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers.
Gelsomino F; Lamberti G; Parisi C; Casolari L; Melotti B; Sperandi F; Ardizzoni A
Cancer Treat Rev; 2019 Sep; 79():101887. PubMed ID: 31491661
[TBL] [Abstract][Full Text] [Related]
33. Use of Immunotherapy in Extensive-Stage Small Cell Lung Cancer.
Konala VM; Madhira BR; Ashraf S; Graziano S
Oncology; 2020; 98(11):749-754. PubMed ID: 32663833
[TBL] [Abstract][Full Text] [Related]
34. Small cell lung cancer: Novel treatments beyond immunotherapy.
Meijer JJ; Leonetti A; Airò G; Tiseo M; Rolfo C; Giovannetti E; Vahabi M
Semin Cancer Biol; 2022 Nov; 86(Pt 2):376-385. PubMed ID: 35568295
[TBL] [Abstract][Full Text] [Related]
35. Immune checkpoint inhibitors in small cell lung cancer.
Pakkala S; Owonikoko TK
J Thorac Dis; 2018 Feb; 10(Suppl 3):S460-S467. PubMed ID: 29593891
[TBL] [Abstract][Full Text] [Related]
36. Novel immunotherapy in the treatment of advanced non-small cell lung cancer.
Santabarbara G; Maione P; Rossi A; Palazzolo G; Gridelli C
Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1571-1581. PubMed ID: 27623999
[TBL] [Abstract][Full Text] [Related]
37. Targeted Therapy and Immune Therapy for Small Cell Lung Cancer.
Gadgeel SM
Curr Treat Options Oncol; 2018 Sep; 19(11):53. PubMed ID: 30203184
[TBL] [Abstract][Full Text] [Related]
38. What Are the Biomarkers for Immunotherapy in SCLC?
Longo V; Catino A; Montrone M; Pizzutilo P; Annese T; Pesola F; Marech I; Cassiano S; Ribatti D; Galetta D
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681779
[TBL] [Abstract][Full Text] [Related]
39. Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways.
Rouanne M; Roumiguié M; Houédé N; Masson-Lecomte A; Colin P; Pignot G; Larré S; Xylinas E; Rouprêt M; Neuzillet Y
World J Urol; 2018 Nov; 36(11):1727-1740. PubMed ID: 29855698
[TBL] [Abstract][Full Text] [Related]
40. Immune checkpoint inhibitors for nonsmall cell lung cancer treatment.
Chen YM
J Chin Med Assoc; 2017 Jan; 80(1):7-14. PubMed ID: 27693088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]